SCHEMBL3875708

SCHEMBL3875708

O=C(O)c1cc2c(nc1C(=O)O)c1cc(C(=O)O)c(C(=O)O)nc1c1cc(C(=O)O)c(C(=O)O)nc21

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.38
KDM4E B2RXH2 3/20 0.38
ALOX15 P16050 3/20 0.38
MAPT P10636 2/20 0.38
TSHR P16473 2/20 0.38
CYP3A4 P08684 1/20 0.38
BLM P54132 1/20 0.38
AGER Q15109 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
SMN1; SMN2 Q16637 2/20 0.37
KEAP1 Q14145 1/20 0.35
NFE2L2 Q16236 1/20 0.35
ASPH Q12797 1/20 0.35
KDM8 Q8N371 1/20 0.35
LMNA P02545 1/20 0.35
PDE10A Q9Y233 1/20 0.35
NR4A1 P22736 1/20 0.34
NR4A2 P43354 1/20 0.34
NR4A3 Q92570 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL258457 0.80 ALDH1A1 (0.43) ALDH1A1KDM4EALOX15MAPTTSHR
SCHEMBL30660932 0.78 ALDH1A1 (0.41) ALDH1A1KDM4EALOX15MAPTTSHR
SCHEMBL29110843 0.78 ALDH1A1 (0.41) ALDH1A1KDM4EALOX15MAPTTSHR
SCHEMBL28202043 0.74 ALDH1A1 (0.49) ALDH1A1KDM4EALOX15MAPTTSHR
SCHEMBL11659284 0.72 POLB (0.35) ASPHKDM8POLB
SCHEMBL9315436 0.71 SMN1; SMN2 (0.50) ALDH1A1KDM4ESMN1; SMN2
SCHEMBL2271379 0.71 ALDH1A1 (0.45) ALDH1A1KDM4EALOX15MAPTTSHR
SCHEMBL2804814 0.70 KDM4E (0.45) ALDH1A1KDM4EMAPTLMNAGRIN2D
SCHEMBL7596408 0.70 ALDH1A1 (0.48) ALDH1A1KDM4EMAPTSMN1; SMN2KEAP1
SCHEMBL8833365 0.70 ALDH1A1 (0.39) ALDH1A1KDM4EALOX15MAPTTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7585928-B2 monomers of acetylenic homo- or copolymers; cured polymers has low dielectric constant as insulating layers in microelectronic devices DOW GLOBAL TECHNOLOGIES (US) 2009-09-08 US disclosed
US-20070027278-A1 Multifunctional monomers containing bound mesogenic poragen forming moieties and polyarylene compositions therefrom DOW GLOBAL TECHNOLOGIES LLC 2007-02-01 US disclosed
US-5637669-A THERMOSETTING RESIN; LIQUID CRYSTALLINE POLYMERS THE DOW CHEMICAL COMPANY (US) 1997-06-10 US disclosed
EP-0670856-A1 THERMOSETTABLE COMPOSITION CONTAINING MESOGENIC MOIETIES THE DOW CHEMICAL COMPANY (US) 1995-09-13 EP disclosed
WO-1994012556-A2 THERMOSETTABLE COMPOSITION CONTAINING DISCOTIC MESOGENIC MOIETIES THE DOW CHEMICAL COMPANY (US) 1994-06-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070027278-A1 Multifunctional monomers containing bound mesogenic poragen forming moieties and polyarylene compositions therefrom LRBA, CD74, BMP2 ALDH1A1 2995/4885KDM4E 4789/4885ALOX15 730/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.